Galenica AG (GALN.S)

GALN.S on Swiss Exchange

710.00CHF
31 Jul 2013
Price Change (% chg)

CHF20.00 (+2.90%)
Prev Close
CHF687.50
Open
CHF694.00
Day's High
CHF714.00
Day's Low
CHF692.50
Volume
56,632
Avg. Vol
21,441
52-wk High
CHF714.00
52-wk Low
CHF479.25

GALN.S

Chart for GALN.S

About

Galenica AG is a Swiss holding company active in the healthcare market. It focuses on two business divisions: Pharma, mainly active in the iron deficiency anemia as well as consumer healthcare area; and Sante, combining products from Retail business sector, Logistics and Information management. The Company divides its activities... (more)

Overall

Beta: 0.63
Market Cap (Mil.): CHF4,615.00
Shares Outstanding (Mil.): 6.50
Dividend: 11.00
Yield (%): 1.55

Financials

  GALN.S Industry Sector
P/E (TTM): 18.19 17.21 39.77
EPS (TTM): 39.04 -- --
ROI: 12.39 10.01 66.51
ROE: 20.26 11.35 72.84
Search Stocks

Galenica shares leap after U.S. approval for anaemia drug

ZURICH, July 26 - Shares in Swiss healthcare company Galenica climbed by more than 8 percent after it announced on Friday that U.S. healthcare regulators had approved its iron deficiency treatment Injectafer.

26 Jul 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$472.00
Provider: Datamonitor
$175.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks